Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

(2021) Ayman Al-Hendy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

(2020) William D. Schlaff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas

(2019) Yutaka Osuga et al.   OBSTETRICS AND GYNECOLOGY

Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women

(2019) Yutaka Osuga et al.   FERTILITY AND STERILITY

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

(2018) Bruce R. Carr et al.   OBSTETRICS AND GYNECOLOGY

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

(2017) David F. Archer et al.   FERTILITY AND STERILITY

Dose-Dependent Suppression of Gonadotropins and Ovarian Hormones by Elagolix in Healthy Premenopausal Women

(2017) Juki Ng et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Uterine Fibroids: Burden and Unmet Medical Need

(2017) Evan Myers et al.   SEMINARS IN REPRODUCTIVE MEDICINE

The impact of uterine leiomyomas: a national survey of affected women

(2013) Bijan J. Borah et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies

(2012) J. P. T. Higgins et al.   Research Synthesis Methods

The burden of uterine fibroids in five European countries

(2010) Ellis Downes et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology